CGTX vs CPBI
Comparison between Cognition Therapeutics Inc (CGTX, Company) and Central Plains Bancshares Inc (CPBI, Company).
CGTX is from the Healthcare sector, while CPBI is from the Financial Services sector.
CGTX vs CPBI - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CGTX vs CPBI - Historical Returns
Returns include dividend reinvestment.
CGTX vs CPBI - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | CGTX | CPBI |
|---|---|---|
| 2026 | -34.68% | +18.09% |
| 2025 | +86.70% | +14.17% |
| 2024 | -63.85% | +41.67% |
| 2023 | -9.76% | +12.09% |
| 2022 | -66.40% | N/A |
| 2021 | -50.51% | N/A |
CGTX vs CPBI Drawdown Comparison
The maximum drawdown for CGTX was -98.16%, occurring on May 30, 2025. This drawdown has not yet recovered.
The maximum drawdown for CPBI was -8.44%, occurring on Apr 10, 2025. Recovery took 124 trading sessions.
The current CGTX drawdown is -92.60%. The current CPBI drawdown is -1.08%.
| Rank | CGTX | CPBI |
|---|---|---|
| #1 | -98.16% Nov 9, 2021 - May 30, 2025 | -8.44% Dec 20, 2024 - Jun 24, 2025 |
| #2 | -6.81% Oct 8, 2021 - Nov 9, 2021 | -7.96% Jan 9, 2024 - Jul 23, 2024 |
| #3 | N/A | -5.39% Jul 31, 2024 - Aug 8, 2024 |
| #4 | N/A | -4.95% Oct 7, 2025 - Dec 12, 2025 |
| #5 | N/A | -4.15% Mar 11, 2026 - May 21, 2026 |
| #6 | N/A | -4.12% Sep 4, 2025 - Sep 29, 2025 |
| #7 | N/A | -4.05% Dec 11, 2024 - Dec 20, 2024 |
| #8 | N/A | -4.00% Dec 4, 2023 - Dec 26, 2023 |
| #9 | N/A | -3.76% Feb 25, 2026 - Mar 11, 2026 |
| #10 | N/A | -3.72% Jan 22, 2026 - Jan 26, 2026 |
| #11 | N/A | -3.65% Nov 3, 2023 - Nov 13, 2023 |
| #12 | N/A | -3.62% Nov 8, 2024 - Dec 11, 2024 |
| #13 | N/A | -3.13% Oct 18, 2024 - Nov 1, 2024 |
| #14 | N/A | -2.88% Oct 11, 2024 - Oct 16, 2024 |
| #15 | N/A | -2.87% Aug 26, 2024 - Sep 19, 2024 |
Correlation
Correlation between CGTX and CPBI is -0.31 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks